APR 27, 2021 7:00 AM PDT

Breakthrough Malaria Vaccine Is a Ray of Hope

WRITTEN BY: Tara Fernandez

University of Oxford scientists have developed a vaccine against malaria, which they describe as having “unprecedented efficacy levels”.

A preprint study details a trial that tested the vaccine in 450 children from Burkina Faso, aged between 5 and 17 months. The participants were randomized to receive either the malaria vaccine or a control rabies vaccine. Shots were timed to be administered just before peak malaria season in the region.

The results were hailed as a breakthrough: The vaccine showed 77 percent efficacy in the higher dose group. This is the first malaria vaccine to meet the World Health Organization’s goal of a vaccine of at least 75 percent efficacy to manage malaria on a global scale.

While the world’s focus is fixed on the ongoing coronavirus pandemic, malaria is of more pressing concern in many African countries. There, data shows that there have been more deaths due to malaria than from COVID-19.

On a molecular level, vaccinating against the parasite that causes malaria is far more complicated than immunizations against SARS-CoV-2. A side-by-side comparison of both these pathogens’ genomes reveals why—malaria parasites have around 5,300 genes, while the coronavirus has around a dozen. Consequently, vaccines need to generate a much higher immune response in order to protect against infection.

"That's a real technical challenge," said Adrian Hill, who led the study. "The vast majority of vaccines haven't worked because it's very difficult." According to Hill, the new vaccine is a game-changer and "has the potential to have a major public health impact".

This is a breakthrough in the field where researchers have spent over a century devising strategies to eradicate or control malaria. Progress has been slow so far, with the disease representing a persistent and significant threat to the public health economic development in many tropical and subtropical regions. With an estimated 300-500 million cases and 2.7 million malaria-related deaths from malaria annually, data from this trial indicate a light at the end of the tunnel.

 

 

Sources: The Lancet preprints, BBC News, Nature.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 24, 2021
Health & Medicine
Myocarditis and COVID-19 Vaccination
AUG 24, 2021
Myocarditis and COVID-19 Vaccination
Myocarditis has been linked to sudden cardiac death in young, healthy athletes and smallpox, influenza, hepatitis B, and ...
AUG 31, 2021
Immunology
Convalescent Plasma Therapy for COVID-19 Doesn't Work
AUG 31, 2021
Convalescent Plasma Therapy for COVID-19 Doesn't Work
After encountering an infectious agent, the immune system begins churning out antibodies—Y-shaped warriors that ne ...
SEP 09, 2021
Drug Discovery & Development
Can vaccines help prevent and treat opioid addiction?
SEP 09, 2021
Can vaccines help prevent and treat opioid addiction?
According to the United States Centers for Disease Control (CDC), 136 people die from an opioid overdose every ...
SEP 14, 2021
Immunology
Extinguishing Fires in the Brains of MS Patients
SEP 14, 2021
Extinguishing Fires in the Brains of MS Patients
  A closer look at the brains of patients with aggressive, debilitating forms of multiple sclerosis (MS) reveals so ...
SEP 23, 2021
Cardiology
Curbing Adverse Cardiovascular Outcomes Through Influenza Vaccination
SEP 23, 2021
Curbing Adverse Cardiovascular Outcomes Through Influenza Vaccination
Influenza is a severe infectious disease. According to the Centers for Disease Control and Prevention the H1N1 strain of ...
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
Loading Comments...